Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
111,130,367
-
Share change
-
+15,977,574
-
Total reported value
-
$4,844,941,896
-
Put/Call ratio
-
36%
-
Price per share
-
$43.60
-
Number of holders
-
229
-
Value change
-
+$734,203,622
-
Number of buys
-
129
-
Number of sells
-
115
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q1 2017
As of 31 Mar 2017,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,130,367 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, BlackRock Inc., GOLDMAN SACHS GROUP INC, BAIN CAPITAL INVESTORS LLC, Aristotle Capital Management, LLC, and Aristotle Capital Management, LLC.
This page lists
229
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.